1 mg Entecavir IP ..

Oct 04, 2023

ENTACOVER 1 
Entecavir IP(1mg)
Entecavir IP (1mg) is a medication used to treat chronic hepatitis B infection (HBV). The "IP" might refer to "Inactive Pharmaceutical Ingredient" or "Indian Pharmacopoeia," but it's not a standard abbreviation for this medication.

ENTACOVER 1  (brand name Baraclude) is an antiviral drug that belongs to the class of medications known as nucleoside analogs. It works by inhibiting the replication of the hepatitis B virus in the body, helping to reduce the viral load in the blood and improve liver function.

Here are some key points to know about ENTACOVER 1 :

Indication: ENTACOVER 1  is prescribed for the treatment of chronic hepatitis B infection in adults and, in some cases, in children who meet specific criteria.

Dosage: The standard recommended dose of ENTACOVER 1  for adults with normal kidney function is typically 1 mg once daily. However, dosages may vary depending on individual factors such as kidney function and the severity of the infection.

Duration of Treatment: Treatment with ENTACOVER 1  is usually long-term and may continue for several years or even indefinitely, as determined by a healthcare provider. The goal is to maintain viral suppression and prevent complications of hepatitis B.

Monitoring: Regular monitoring of liver function and viral load is essential during treatment to assess the medication's effectiveness.

Side Effects: Common side effects of ENTACOVER 1  may include headache, dizziness, fatigue, and nausea. Any unusual or severe side effects should be reported to a healthcare provider.

Precautions: Entecavir should not be stopped abruptly without consulting a healthcare provider, as discontinuation can lead to a hepatitis B flare-up. It's important to follow the prescribed treatment plan.

Pregnancy and Breastfeeding: If you are pregnant or breastfeeding, it's essential to discuss the use of Entecavir with your healthcare provider, as the risks and benefits need to be carefully considered.

Entecavir is typically prescribed by specialists in infectious diseases or hepatology (liver diseases) who can monitor your progress and make any necessary adjustments to your treatment plan. If you have any questions or concerns about Entecavir or your hepatitis B treatment, be sure to discuss them with your healthcare provider for personalized guidance.
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
contact@sterispharma.com
order now:
sterisonline.com

SHARE WITH